Donal O'Shea
Professor Donal O'Shea is a chief obesity clinician who recently expressed shock at the prevalence of black market 'skinny jabs' like Ozempic, underlining the ethical and health implications surrounding the rise of these weight-loss medications.
Global Media Ratings
Countries Mentioned
| Country | Mentions | Sentiment | Dominance | + Persistence | x Population | = Reach | x GDP (millions) | = Power |
|---|---|---|---|---|---|---|---|---|
| Ireland | 1 | 6.00 | 0.07% | +0% | 5,030,000 | 3,445 | $5,100 | 3$ |
| Totals | 1 | 5,030,000 | 3,445 | $5,100 | 3$ |
Interactive World Map
Each country's color is based on "Mentions" from the table above.
Recent Mentions
Ireland:
Prof Donal O’Shea, a consultant endocrinologist at the National Gender Service, has brought the judicial review proceedings.
6
Brazil:
Donal O'Shea is a professor of Chemistry at the RCSI University of Medicine and Health Sciences.
7
Ireland:
Prof Donal O’Shea is the HSE lead on obesity who praised the new weight-loss pill as a landmark moment.
9
Ireland:
Prof O’Shea is taking legal action against the Health Information and Quality Authority over the treatment of children with gender identity issues.
7
Ireland:
Prof Donal O'Shea was shocked at the prevalence of black market 'skinny jabs'.
5